EMPLICITI (elotuzumab) for injection

Bristol-Myers Squibb Australia Pty Ltd

Revision date : 2016-11-29

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
Health risk rating
Safety risk rating
Environmental risk rating

Note: Ingredients listed on restricted chemical lists

EC/CAS

57-50-1

Name of the chemical

Sucrose, pure C12H22O11

Concentration

39% <60% <5%

General Information

Revision date

2016-11-29

Product name

EMPLICITI (elotuzumab) for injection

Product Synonyms

Empliciti (elotuzumab)300 mg/vial and 400 mg/vial, Elotuzumab Lyophilized powder

1.2.1 Relevant identified uses

This material is a finished drug product for patient use. It is used in the treatment of cancer. It is a protein

Emergency telephone

+(61)-290372994

Icons in SDS

Company Information

company name

Bristol-Myers Squibb Australia Pty Ltd

Section 2

SECTION 2: Hazards identification

UN Globally Harmonized System (GHS)

2.1 Classification of the substance or mixture

Not Rated Substance not fully tested.

Precautionary statements

Wash hands after handling to minimize exposure. Handle as a potentially hazardous material. Avoid ingestion, inhalation, skin and eye contact.

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.